Prof Ming-Wei Lin is a Senior Staff Specialist in Clinical Immunology and Director of Immunopathology at Westmead Hospital and ICPMR. Her special interests include autoimmunity, primary immunodeficiency, and diagnostic immunopathology. She is deeply committed to teaching and training, supervising advanced trainees in both clinical and laboratory immunology, and is a sought-after speaker at national and international conferences. She led the establishment of the ICI Toxicity Working Party at Westmead, through which she and her colleagues published local guidelines on the investigation and management of “Triple M”, one of the most severe immune checkpoint inhibitor toxicity.